‘V-Day’ in the UK, Delays in the US

“It’s the best early birthday present I could wish for…”
 
This morning a 90-year-old shop clerk named Margaret Keenan received Britain’s first dose of the Pfizer/BioNTech COVID-19 vaccine as the country rolls out its fledgling vaccination program, starting with people over 80, AP reports. 
 
Breaking US News: The Pfizer/BioNTech vaccine is safe and effective, according to a much-anticipated FDA analysis released this morning, priming vaccine for an emergency use authorization, NPR reports.

Independent FDA advisors will convene Thursday to consider recommending the FDA grant the Pfizer vaccine an EUA.

Later Today: The White House will convene a “Vaccine Summit,” which has been dubbed a publicity stunt to “claim credit” for rapid vaccine development, even as the UK pulls out in front and the White House has reportedly been grilling the FDA about its approval timeline, STAT reports.
 
On the Agenda: President Trump plans to sign an executive order that aim to ensure Americans get priority access before doses are shipped abroad to help other countries, ABC reports.
 
Pfizer and Moderna—the companies behind the top 2 vaccine candidates—declined to attend, underscoring the rising acrimony between the Trump administration and drugmakers.
 
Latest Revelation: This summer, the White House opted out of a deal to lock in 100 million additional doses of the Pfizer vaccine, which may delay US delivery further as the company fulfills commitments to other countries, AP reports.